TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kilitch Drugs (India) Limited ( (IN:KILITCH) ) has issued an announcement.
Kilitch Drugs (India) Limited has submitted its Monitoring Agency Report for the quarter ending September 30, 2025, in compliance with SEBI regulations. This report, prepared by Infomerics Valuation and Rating Limited, reflects the company’s adherence to regulatory requirements and will be available on the company’s website, indicating transparency and accountability to stakeholders.
More about Kilitch Drugs (India) Limited
Kilitch Drugs (India) Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of pharmaceutical products. The company is known for its commitment to quality and compliance with international standards, as evidenced by its WHO certification.
Average Trading Volume: 3,760
Technical Sentiment Signal: Buy
Current Market Cap: 6.48B INR
See more data about KILITCH stock on TipRanks’ Stock Analysis page.